News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
470,165 Results
Type
Article (32068)
Company Profile (42)
Press Release (438055)
Multimedia
Podcasts (78)
Webinars (8)
Section
Business (141652)
Career Advice (1731)
Deals (21359)
Drug Delivery (70)
Drug Development (60340)
Employer Resources (114)
FDA (11589)
Job Trends (10270)
News (238683)
Policy (22487)
Tag
Academia (2181)
Academic (1)
Accelerated approval (4)
Adcomms (16)
Allergies (60)
Alliances (37768)
ALS (75)
Alzheimer's disease (1195)
Antibody-drug conjugate (ADC) (82)
Approvals (11611)
Artificial intelligence (206)
Autoimmune disease (18)
Automation (14)
Bankruptcy (210)
Best Places to Work (8537)
BIOSECURE Act (8)
Biosimilars (57)
Biotechnology (34)
Bladder cancer (71)
Brain cancer (19)
Breast cancer (221)
Cancer (1804)
Cardiovascular disease (154)
Career advice (1454)
Career pathing (27)
CAR-T (111)
Cell therapy (333)
Cervical cancer (16)
Clinical research (48879)
Collaboration (689)
Compensation (244)
Complete response letters (12)
COVID-19 (1838)
CRISPR (37)
C-suite (154)
Cystic fibrosis (72)
Data (1912)
Decentralized trials (2)
Denatured (24)
Depression (31)
Diabetes (234)
Diagnostics (4427)
Digital health (11)
Diversity (3)
Diversity, equity & inclusion (38)
Drug discovery (92)
Drug pricing (71)
Drug shortages (23)
Duchenne muscular dystrophy (84)
Earnings (62411)
Editorial (33)
Employer branding (13)
Employer resources (100)
Events (70885)
Executive appointments (506)
FDA (12592)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (524)
Gene editing (85)
Generative AI (22)
Gene therapy (285)
GLP-1 (585)
Government (3262)
Grass and pollen (4)
Guidances (69)
Healthcare (13646)
Huntington's disease (17)
IgA nephropathy (26)
Immunology and inflammation (83)
Indications (25)
Infectious disease (1945)
Inflammatory bowel disease (105)
Inflation Reduction Act (8)
Influenza (34)
Intellectual property (74)
Interviews (300)
IPO (10232)
IRA (29)
Job creations (2091)
Job search strategy (1230)
Kidney cancer (8)
Labor market (23)
Layoffs (280)
Leadership (18)
Legal (5263)
Liver cancer (46)
Lung cancer (247)
Lymphoma (128)
Machine learning (4)
Management (38)
Manufacturing (209)
MASH (75)
Medical device (8894)
Medtech (8898)
Mergers & acquisitions (11532)
Metabolic disorders (588)
Multiple sclerosis (60)
NASH (20)
Neurodegenerative disease (73)
Neuropsychiatric disorders (19)
Neuroscience (1616)
NextGen: Class of 2025 (4487)
Non-profit (3563)
Now hiring (32)
Obesity (290)
Opinion (183)
Ovarian cancer (53)
Pain (81)
Pancreatic cancer (64)
Parkinson's disease (110)
Partnered (16)
Patents (173)
Patient recruitment (86)
Peanut (30)
People (36212)
Pharmaceutical (12)
Pharmacy benefit managers (10)
Phase I (14700)
Phase II (21486)
Phase III (16631)
Pipeline (1054)
Policy (101)
Postmarket research (2173)
Preclinical (6754)
Press Release (40)
Prostate cancer (101)
Psychedelics (23)
Radiopharmaceuticals (194)
Rare diseases (295)
Real estate (3114)
Recruiting (42)
Regulatory (15544)
Reports (23)
Research institute (1779)
Resumes & cover letters (271)
Rett syndrome (5)
RNA editing (3)
RSV (36)
Schizophrenia (59)
Series A (85)
Series B (53)
Service/supplier (4)
Sickle cell disease (40)
Special edition (7)
Spinal muscular atrophy (101)
Sponsored (20)
Startups (2085)
State (1)
Stomach cancer (9)
Supply chain (40)
Tariffs (22)
The Weekly (53)
Vaccines (501)
Venture capitalists (21)
Weight loss (190)
Women's health (20)
Worklife (13)
Date
Today (136)
Last 7 days (602)
Last 30 days (2021)
Last 365 days (24217)
2025 (8304)
2024 (25667)
2023 (28587)
2022 (36147)
2021 (38638)
2020 (37547)
2019 (32842)
2018 (24615)
2017 (22932)
2016 (22196)
2015 (25779)
2014 (20860)
2013 (17733)
2012 (18031)
2011 (17748)
2010 (16632)
Location
Africa (628)
Alabama (43)
Alaska (4)
Arizona (106)
Arkansas (8)
Asia (26393)
Australia (4751)
California (4408)
Canada (1474)
China (390)
Colorado (195)
Connecticut (216)
Delaware (100)
Europe (62223)
Florida (701)
Georgia (166)
Idaho (32)
Illinois (391)
India (20)
Indiana (245)
Iowa (5)
Japan (130)
Kansas (79)
Kentucky (13)
Louisiana (7)
Maine (47)
Maryland (637)
Massachusetts (3211)
Michigan (161)
Minnesota (234)
Missouri (48)
Montana (15)
Nebraska (15)
Nevada (46)
New Hampshire (46)
New Jersey (1387)
New Mexico (15)
New York (1332)
North Carolina (742)
North Dakota (5)
Northern California (1962)
Ohio (152)
Oklahoma (11)
Oregon (25)
Pennsylvania (998)
Puerto Rico (6)
Rhode Island (21)
South America (872)
South Carolina (16)
South Dakota (1)
Southern California (1704)
Tennessee (76)
Texas (659)
United States (16850)
Utah (132)
Virginia (105)
Washington D.C. (47)
Washington State (429)
West Virginia (2)
Wisconsin (32)
470,165 Results for "vince and associates".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
VION Biosciences Names Vince Stoyanov as Chief Strategy and Development Officer
January 8, 2025
·
2 min read
Drug Development
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024
Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today presented positive preliminary Phase 1 data for VIP236 and updates on pipeline progress at the American Association for Cancer Research (AACR) Annual Meeting 2024.
April 8, 2024
·
11 min read
Drug Development
Dr. Vince Clinical Research Announces First Dosing in a Phase II Study in Patients With Depression
Dr. Vince Clinical Research (DVCR), a contract research organization (CRO) specializing in early phase trials, announced the first dosing in a Phase II multicenter trial of SPN-820 in adults with major depressive disorder (MDD). DVCR is acting as the full-service CRO for this trial.
March 13, 2024
·
3 min read
Press Releases
Bluejay Therapeutics Announces Upcoming Presentation of Preclinical Data in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at European Association for the Study of the Liver (EASL) Congress 2025
April 23, 2025
·
4 min read
Press Releases
Adeno-associated Virus Gene Therapy Market Size to Reach USD 107.2 Billion by 2035, Impelled by Advancements in Personalized Medicine.
Adeno-associated Virus Gene Therapy Market Outlook 2025-2035:
February 17, 2025
·
11 min read
Business
Dr. Vince Clinical Research, Clario Form Strategic Partnership to Deliver Innovative Cardiac Assessments in Clinical Trials
Dr. Vince Clinical Research, an early phase Clinical Research Organization, announced a new collaboration with Clario, a leading healthcare research and technology company that delivers leading endpoint technology solutions for clinical trials.
August 29, 2023
·
5 min read
Business
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today reported financial results for the first quarter of 2024 and provided a corporate update.
May 14, 2024
·
13 min read
Press Releases
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
March 5, 2025
·
7 min read
Press Releases
Doer Biologics Announces First Patient Dosed in Phase 2 Study of DR10624 for Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
April 23, 2025
·
2 min read
Drug Development
Dr. Vince Clinical Research Announces First Dosing in Cingulate Therapeutics’ CTx-1301 Phase III Laboratory Classroom Study in ADHD Patients
Dr. Vince Clinical Research (DVCR), a full-service clinical research organization (CRO), today announced the first dosing in Cingulate Therapeutics’ CTx-1301 Phase III dose-optimization onset and duration laboratory classroom study.
September 6, 2023
·
3 min read
1 of 47,017
Next
